Screener
CANC vs RSHO
Tema Oncology ETF vs Tema American Reshoring ETF
Key differences
- CANC follows a index tracking strategy; RSHO uses active selection.
Side-by-side comparison
| CANC | RSHO | |
|---|---|---|
| Annual cost (TER) | 0.75% | 0.75% |
| Fund size (AUM) | $176M | $263M |
| Since | 2023 | 2023 |
| Dividend yield | 0.05% | 0.23% |
| Asset class | equity | equity |
| Region | — | north america |
| Strategy | index tracking | active selection |
| CAGR 1Y | +57.7% | +52.3% |
| CAGR 3Y | N/A | +30.9% |
| CAGR 5Y | N/A | N/A |
| Sharpe 3Y | N/A | 1.15 |
| Volatility 1Y | 23.33% | 23.51% |
| Max drawdown | -28.17% | -27.31% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to CANC and RSHO
Explore further